Table 3.

Lineage Expression by Engrafted Donor (Ly-5.1) Cells in Individual Mice at 5 Months Posttransplantation

Cytokines Mice % B220+ Cells % Thy-1.2+ Cells % Gr-1+, Mac-1+ Cells % Total Myeloid/Lymphoid Ratio
No culture  1  4.8  3.1  2.6  10.5  0.33 
 2  35.5  22.7  14.7  72.9  0.25  
 33.5  20.5  19.6  73.6  0.36  
 4  33.4 21.2  13.5  68.1  0.25  
 5  8.4  6.2  2.4 17.0  0.16  
 6  24.9  18.5  19.9  63.3 0.46  
 7  20.0  17.5  6.5  44.0  0.17 
 8  23.3  22.8  8.6  54.7  0.19  
 10.0  8.5  1.2  19.7  0.06  
 10  32.7  27.3 7.5  67.5  0.13  
 Mean ± SD    49.1 ± 24.7  0.24 ± 0.12* 
TPO  1.9  1.4  1.1  4.4  0.33  
 2  35.9  26.7 22.6  85.2  0.36  
 3  1.7  1.5  1.2  4.4 0.38  
 4  13.8  9.0  5.6  28.4  0.25  
 3.5  2.4  1.5  7.4  0.25  
 6  5.8  3.9 2.2  11.9  0.23  
 7    0.9 
 8  22.7  17.6  10.4  50.7  0.26 
 Mean ± SD    24.2 ± 29.8  0.29 ± 0.06* 
TPO, FL  0.9  0.6  0.8  2.3  0.53  
 2  0.9  0.6 0.7  2.2  0.47  
 3  27.5  25.5  5.0  58.0 0.09  
 4  1.4  1.1  1.1  3.6  0.44  
 20.4  20.4  12.1  36.5  0.30  
 6  32.5 19.8  15.2  67.5  0.29  
 7    0.9  
 8  3.8  2.4  1.4  7.6  0.23 
 9  2.9  1.4  1.3  5.6  0.30 
 Mean ± SD    20.4 ± 26.4  0.33 ± 0.14* 
IL-6, FL  19.2  8.6  6.5  34.3  0.23  
 2  17.9  12.4 8.5  38.8  0.28  
 3  37.3  32.2  22.7  92.2 0.33  
 4  6.4  3.0  3.3  12.7  0.35  
 18.0  8.6  7.9  34.5  0.30  
 6  17.4  10.1 3.9  31.4  0.14  
 7  7.3  4.7  1.3  13.3 0.11  
 8  3.2  1.0  1.1  5.3  0.26  
 15.5  14.9  2.5  32.9  0.08 
 Mean ± SD    32.8 ± 25.3  0.23 ± 0.10* 
Cytokines Mice % B220+ Cells % Thy-1.2+ Cells % Gr-1+, Mac-1+ Cells % Total Myeloid/Lymphoid Ratio
No culture  1  4.8  3.1  2.6  10.5  0.33 
 2  35.5  22.7  14.7  72.9  0.25  
 33.5  20.5  19.6  73.6  0.36  
 4  33.4 21.2  13.5  68.1  0.25  
 5  8.4  6.2  2.4 17.0  0.16  
 6  24.9  18.5  19.9  63.3 0.46  
 7  20.0  17.5  6.5  44.0  0.17 
 8  23.3  22.8  8.6  54.7  0.19  
 10.0  8.5  1.2  19.7  0.06  
 10  32.7  27.3 7.5  67.5  0.13  
 Mean ± SD    49.1 ± 24.7  0.24 ± 0.12* 
TPO  1.9  1.4  1.1  4.4  0.33  
 2  35.9  26.7 22.6  85.2  0.36  
 3  1.7  1.5  1.2  4.4 0.38  
 4  13.8  9.0  5.6  28.4  0.25  
 3.5  2.4  1.5  7.4  0.25  
 6  5.8  3.9 2.2  11.9  0.23  
 7    0.9 
 8  22.7  17.6  10.4  50.7  0.26 
 Mean ± SD    24.2 ± 29.8  0.29 ± 0.06* 
TPO, FL  0.9  0.6  0.8  2.3  0.53  
 2  0.9  0.6 0.7  2.2  0.47  
 3  27.5  25.5  5.0  58.0 0.09  
 4  1.4  1.1  1.1  3.6  0.44  
 20.4  20.4  12.1  36.5  0.30  
 6  32.5 19.8  15.2  67.5  0.29  
 7    0.9  
 8  3.8  2.4  1.4  7.6  0.23 
 9  2.9  1.4  1.3  5.6  0.30 
 Mean ± SD    20.4 ± 26.4  0.33 ± 0.14* 
IL-6, FL  19.2  8.6  6.5  34.3  0.23  
 2  17.9  12.4 8.5  38.8  0.28  
 3  37.3  32.2  22.7  92.2 0.33  
 4  6.4  3.0  3.3  12.7  0.35  
 18.0  8.6  7.9  34.5  0.30  
 6  17.4  10.1 3.9  31.4  0.14  
 7  7.3  4.7  1.3  13.3 0.11  
 8  3.2  1.0  1.1  5.3  0.26  
 15.5  14.9  2.5  32.9  0.08 
 Mean ± SD    32.8 ± 25.3  0.23 ± 0.10* 

Lineage expression of the engrafted donor cells was analyzed at 5 months posttransplantation. Background (peripheral blood of nontransplanted male mice) staining by anti–Ly-5.1 MoAb (A20-1.7) was less than 1.0%. Because the donor cells in the recipient mice that had been transplanted with cells cultured with FL or IL-6 alone showed less than 1.0%, analysis of lineage phenotypes was not performed.

*

There were no significant differences of the myeloid (Gr-1+, Mac-1+ cells)/lymphoid (B220+ cells and Thy-1.2+ cells) ratios among the experimental groups by unpaired t-test.

Because no donor cells were detected in these animals, analysis of lineage phenotypes was not performed.

or Create an Account

Close Modal
Close Modal